Lenvatinib/Pembrolizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of lenvatinib and pembrolizumab that may be used for the treatment of cutaneous melanoma, hepatobiliary cancers, advanced endometrial carcinoma, advanced renal cell carcinoma (RCC), follicular carcinoma, papillary carcinoma, and anaplastic thryoid carcinoma.

**Synonyms:** - Keytruda/Lenvima - Lenvatinib and Pembrolizumab - Lenvatinib-Pembrolizumab - Lenvatinib/Pembrolizumab - Pembrolizumab-Lenvatinib - Pembrolizumab/Lenvatinib - Pembrolizumab/Lenvatinib Regimen